Publications

Adami J, Gridley G, Nyren O, Dosemeci M, et al. (1999). Sunlight and non-Hodgkin's lymphoma: a population-based cohort study in Sweden. Int. J. Cancer 80: 641-645. http://dx.doi.org/10.1002/(SICI)1097-0215(19990301)80:5<641::AID-IJC1>3.0.CO;2-Z   Agopian J, Navarro JM, Gac AC, Lecluse Y, et al. (2009). Agricultural pesticide exposure and the molecular connection to lymphomagenesis. J. Exp. Med. 206: 1473-1483. http://dx.doi.org/10.1084/jem.20082842 PMid:19506050 PMCid:2715093   Armitage JO and Weisenburger DD (1998). New approach to classifying non-Hodgkin's lymphomas: clinical features of the major histologic subtypes. Non-Hodgkin's Lymphoma Classification Project. J. Clin. Oncol. 16: 2780-2795. PMid:9704731   Bell DA, Liu Y and Cortopassi GA (1995). Occurrence of bcl-2 oncogene translocation with increased frequency in the peripheral blood of heavy smokers. J. Natl. Cancer Inst. 87: 223-224. http://dx.doi.org/10.1093/jnci/87.3.223 PMid:7707410   Bentham G, Wolfreys AM, Yafei L, Cortopassi G, et al. (1999). Frequencies of hprt- mutations and bcl-2 translocations in circulating human lymphocytes are correlated with United Kingdom sunlight records. Mutagenesis 14: 527-532. http://dx.doi.org/10.1093/mutage/14.6.527 PMid:10567026   Cleary ML and Sklar J (1985). Nucleotide sequence of a t(14;18) chromosomal breakpoint in follicular lymphoma and demonstration of a breakpoint-cluster region near a transcriptionally active locus on chromosome 18. Proc. Natl. Acad. Sci. U. S. A. 82: 7439-7443. http://dx.doi.org/10.1073/pnas.82.21.7439 PMid:2865728 PMCid:391360   da Cruz AD, de Melo e Silva, da Silva CC, Nelson RJ, et al. (2008). Microsatellite mutations in the offspring of irradiated parents 19 years after the Cesium-137 accident. Mutat. Res. 652: 175-179. http://dx.doi.org/10.1016/j.mrgentox.2008.02.002 PMid:18346932   Deininger MW, Bose S, Gora-Tybor J, Yan XH, et al. (1998). Selective induction of leukemia-associated fusion genes by high-dose ionizing radiation. Cancer Res. 58: 421-425. PMid:9458083   Dölken G, Illerhaus G, Hirt C and Mertelsmann R (1996). BCL-2/JH rearrangements in circulating B cells of healthy blood donors and patients with nonmalignant diseases. J. Clin. Oncol. 14: 1333-1344. PMid:8648392   Dölken G, Dölken L, Hirt C, Fusch C, et al. (2008). Age-dependent prevalence and frequency of circulating t(14;18)-H.F. Nunes et al. positive cells in the peripheral blood of healthy individuals. J. Natl. Cancer Inst. Monogr. 39: 44-47. http://dx.doi.org/10.1093/jncimonographs/lgn005 PMid:18648002   Dölken L, Schüler F and Dölken G (2002). Frequency of BCL-2/J(H) translocation in healthy males exposed to low-level radiation in comparison to age-matched health controls. Blood 100: 1513-1514. http://dx.doi.org/10.1182/blood-2002-03-0887 PMid:12184277   Fuscoe JC, Setzer RW, Collard DD and Moore MM (1996). Quantification of t(14;18) in the lymphocytes of healthy adult humans as a possible biomarker for environmental exposures to carcinogens. Carcinogenesis 17: 1013-1020. http://dx.doi.org/10.1093/carcin/17.5.1013 PMid:8640906   Jager U, Bocskor S, Le T, Mitterbauer G, et al. (2000). Follicular lymphomas' BCL-2/IgH junctions contain templated nucleotide insertions: novel insights into the mechanism of t(14;18) translocation. Blood 95: 3520-3529. PMid:10828038   Limpens J, de Jong D, van Krieken JH, Price CG, et al. (1991). Bcl-2/JH rearrangements in benign lymphoid tissues with follicular hyperplasia. Oncogene 6: 2271-2276. PMid:1766674   Mahfouz R, Shammaa D, Tawil A and Zaatari G (2007). Molecular frequency of BCL2/JH t(14; 18) using PCR among Lebanese patients with follicular lymphoma: another piece of the geographical map revealed. Mol. Biol. Rep. 34: 271-274. http://dx.doi.org/10.1007/s11033-006-9042-6 PMid:17149654   McDonnell TJ and Korsmeyer SJ (1991). Progression from lymphoid hyperplasia to high-grade malignant lymphoma in mice transgenic for the t(14; 18). Nature 349: 254-256. http://dx.doi.org/10.1038/349254a0 PMid:1987477   Rabkin CS, Hirt C, Janz S and Dölken G (2008). t(14;18) Translocations and risk of follicular lymphoma. J. Natl. Cancer Inst. Monogr. 48-51. http://dx.doi.org/10.1093/jncimonographs/lgn002 PMid:18648003   Schüler F, Hirt C and Dölken G (2003). Chromosomal translocation t(14;18) in healthy individuals. Semin. Cancer Biol. 13: 203-209. http://dx.doi.org/10.1016/S1044-579X(03)00016-6   Yasukawa M, Bando S, Dölken G, Sada E, et al. (2001). Low frequency of BCL-2/J(H) translocation in peripheral blood lymphocytes of healthy Japanese individuals. Blood 98: 486-488. http://dx.doi.org/10.1182/blood.V98.2.486 PMid:11435322

Amthor H, Nicholas G, McKinnell I, Kemp CF, et al. (2004). Follistatin complexes Myostatin and antagonises Myostatin-mediated inhibition of myogenesis. Dev. Biol. 270: 19-30. http://dx.doi.org/10.1016/j.ydbio.2004.01.046 PMid:15136138   Diel P, Schiffer T, Geisler S, Hertrampf T, et al. (2010). Analysis of the effects of androgens and training on myostatin propeptide and follistatin concentrations in blood and skeletal muscle using highly sensitive immuno PCR. Mol. Cell Endocrinol. 330: 1-9. http://dx.doi.org/10.1016/j.mce.2010.08.015 PMid:20801187   Dinh P, Hazel A, Palispis W, Suryadevara S, et al. (2009). Functional assessment after sciatic nerve injury in a rat model. Microsurgery 29: 644-649. http://dx.doi.org/10.1002/micr.20685 PMid:19653327   Gilson H, Schakman O, Kalista S, Lause P, et al. (2009). Follistatin induces muscle hypertrophy through satellite cell proliferation and inhibition of both myostatin and activin. Am. J. Physiol. Endocrinol. Metab. 297: E157-E164. http://dx.doi.org/10.1152/ajpendo.00193.2009 PMid:19435857   Hill JJ, Davies MV, Pearson AA, Wang JH, et al. (2002). The myostatin propeptide and the follistatin-related gene are inhibitory binding proteins of myostatin in normal serum. J. Biol. Chem. 277: 40735-40741. http://dx.doi.org/10.1074/jbc.M206379200 PMid:12194980   Lakshman KM, Bhasin S, Corcoran C, Collins-Racie LA, et al. (2009). Measurement of myostatin concentrations in human serum: Circulating concentrations in young and older men and effects of testosterone administration. Mol. Cell Endocrinol. 302: 26-32. http://dx.doi.org/10.1016/j.mce.2008.12.019 PMid:19356623   Lee SJ (2010). Extracellular regulation of myostatin: A molecular rheostat for muscle mass. Immunol. Endocr. Metab. Agents Med. Chem. 10: 183-194. http://dx.doi.org/10.2174/187152210793663748 PMid:21423813 PMCid:3060380   Lee SJ and McPherron AC (2001). Regulation of myostatin activity and muscle growth. Proc. Natl. Acad. Sci. U. S. A. 98: 9306-9311. http://dx.doi.org/10.1073/pnas.151270098 PMid:11459935 PMCid:55416   Lee SJ, Lee YS, Zimmers TA, Soleimani A, et al. (2010). Regulation of muscle mass by follistatin and activins. Mol. Endocrinol. 24: 1998-2008. http://dx.doi.org/10.1210/me.2010-0127 PMid:20810712 PMCid:2954636   Liu M, Zhang D, Shao C, Liu J, et al. (2007). Expression pattern of myostatin in gastrocnemius muscle of rats after sciatic nerve crush injury. Muscle Nerve 35: 649-656. http://dx.doi.org/10.1002/mus.20749 PMid:17326119   Matzuk MM, Lu N, Vogel H, Sellheyer K, et al. (1995). Multiple defects and perinatal death in mice deficient in follistatin. Nature 374: 360-363. http://dx.doi.org/10.1038/374360a0 PMid:7885475   McPherron AC, Lawler AM and Lee SJ (1997). Regulation of skeletal muscle mass in mice by a new TGF-beta superfamily member. Nature 387: 83-90. http://dx.doi.org/10.1038/387083a0 PMid:9139826   Rodino-Klapac LR, Haidet AM, Kota J, Handy C, et al. (2009). Inhibition of myostatin with emphasis on follistatin as a therapy for muscle disease. Muscle Nerve 39: 283-296. http://dx.doi.org/10.1002/mus.21244 PMid:19208403 PMCid:2717722   Thies RS, Chen T, Davies MV, Tomkinson KN, et al. (2001). GDF-8 propeptide binds to GDF-8 and antagonizes biological activity by inhibiting GDF-8 receptor binding. Growth Factors 18: 251-259. http://dx.doi.org/10.3109/08977190109029114 PMid:11519824   Thompson TB, Lerch TF, Cook RW, Woodruff TK, et al. (2005). The structure of the follistatin:activin complex reveals antagonism of both type I and type II receptor binding. Dev. Cell 9: 535-543. http://dx.doi.org/10.1016/j.devcel.2005.09.008 PMid:16198295   Ueno N, Ling N, Ying SY, Esch F, et al. (1987). Isolation and partial characterization of follistatin: a single-chain Mr 35,000 monomeric protein that inhibits the release of follicle-stimulating hormone. Proc. Natl. Acad. Sci. U. S. A. 84: 8282-8286. http://dx.doi.org/10.1073/pnas.84.23.8282 PMid:3120188 PMCid:299526   Wallimann T, Wyss M, Brdiczka D, Nicolay K, et al. (1992). Intracellular compartmentation, structure and function of creatine kinase isoenzymes in tissues with high and fluctuating energy demands: the 'phosphocreatine circuit' for cellular energy homeostasis. Biochem. J. 281: 21-40. PMid:1731757 PMCid:1130636   Whittemore LA, Song K, Li X, Aghajanian J, et al. (2003). Inhibition of myostatin in adult mice increases skeletal muscle mass and strength. Biochem. Biophys. Res. Commun. 300: 965-971. http://dx.doi.org/10.1016/S0006-291X(02)02953-4   Wolfman NM, McPherron AC, Pappano WN, Davies MV, et al. (2003). Activation of latent myostatin by the BMP-1/ tolloid family of metalloproteinases. Proc. Natl. Acad. Sci. U. S. A. 100: 15842-15846. http://dx.doi.org/10.1073/pnas.2534946100 PMid:14671324 PMCid:307655   Zhang D, Liu M, Ding F and Gu X (2006). Expression of myostatin RNA transcript and protein in gastrocnemius muscle of rats after sciatic nerve resection. J. Muscle Res. Cell Motil. 27: 37-44. http://dx.doi.org/10.1007/s10974-005-9050-5 PMid:16450055

Brinkmann AO and Trapman J (2000). Genetic analysis of androgen receptors in development and disease. Adv. Pharmacol. 47: 317-341. http://dx.doi.org/10.1016/S1054-3589(08)60115-5   Domenice S, Costa EMF, Corrêa RV and Mendonça BB (2002). Molecular aspects of sexual determination and differentiation. [Aspectos moleculares da determinação e diferenciação sexual]. Arq. Bras. Endocrinol. Metab. 46: 433-443. http://dx.doi.org/10.1590/S0004-27302002000400015   Eskenazi B, Wyrobek AJ, Sloter E, Kidd SA, et al. (2003). The association of age and semen quality in healthy men. Hum. Reprod. 18: 447-454. http://dx.doi.org/10.1093/humrep/deg107 PMid:12571189   Ferlin A, Bartoloni L, Rizzo G, Roverato A, et al. (2004). Androgen receptor gene CAG and GGC repeat lengths in idiopathic male infertility. Mol. Hum. Reprod. 10: 417-421. http://dx.doi.org/10.1093/molehr/gah054 PMid:15044606   Fuentes-Mascorro G, Serrano H and Rosado A (2000). Sperm chromatin. Arch. Androl. 45: 215-225. http://dx.doi.org/10.1080/01485010050193995 PMid:11111870   Genetics and Molecular Research 9 (1): 128-133 (2010) ©FUNPEC-RP www.funpecrp.com.br   Male infertility and androgen receptor mutations   Gottlieb B, Lombroso R, Beitel LK and Trifiro MA (2005). Molecular pathology of the androgen receptor in male (in)fertility. Reprod. Biomed. (Online) 10: 42-48. http://dx.doi.org/10.1016/S1472-6483(10)60802-4   Holdcraft RW and Braun RE (2004). Androgen receptor function is required in Sertoli cells for the terminal differentiation of haploid spermatids. Development 131: 459-467. http://dx.doi.org/10.1242/dev.00957 PMid:14701682   Kunzle R, Mueller MD, Hanggi W, Birkhauser MH, et al. (2003). Semen quality of male smokers and nonsmokers in infertile couples. Fertil. Steril. 79: 287-291. http://dx.doi.org/10.1016/S0015-0282(02)04664-2   Lim J, Ghadessy FJ, Abdullah AA, Pinsky L, et al. (2000). Human androgen receptor mutation disrupts ternary interactions between ligand, receptor domains, and the coactivator TIF2 (transcription intermediary factor 2). Mol. Endocrinol. 14: 1187-1197. http://dx.doi.org/10.1210/me.14.8.1187 PMid:10935543   Lopes S, Jurisicova A, Sun JG and Casper RF (1998). Reactive oxygen species: potential cause for DNA fragmentation in human spermatozoa. Hum. Reprod. 13: 896-900. http://dx.doi.org/10.1093/humrep/13.4.896 PMid:9619544   Lubahn DB, Joseph DR, Sullivan PM, Willard HF, et al. (1988). Cloning of human androgen receptor complementary DNA and localization to the X chromosome. Science 240: 327-330. http://dx.doi.org/10.1126/science.3353727 PMid:3353727   Sailer BL, Jost LK and Evenson DP (1995). Mammalian sperm DNA susceptibility to in situ denaturation associated with the presence of DNA strand breaks as measured by the terminal deoxynucleotidyl transferase assay. J. Androl. 16: 80-87. PMid:7768756   Uehara S, Hashiyada M, Sato K, Sato Y, et al. (2001). Preferential X-chromosome inactivation in women with idiopathic recurrent pregnancy loss. Fertil. Steril. 76: 908-914. http://dx.doi.org/10.1016/S0015-0282(01)02845-X   Yong EL, Loy CJ and Sim KS (2003). Androgen receptor gene and male infertility. Hum. Reprod. Update 9: 1-7. http://dx.doi.org/10.1093/humupd/dmg003 PMid:12638777